-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cisplatin in Oral Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cisplatin in Oral Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cisplatin in Oral CancerDrug Details:Cisplatin nanoparticle is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – cisplatin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry cisplatin Drug Details Cisplatin nanoparticle is under development for the treatment of oral squamous...